Details for Patent: 9,226,903

Which drugs does patent 9,226,903 protect, and when does it expire?

Patent 9,226,903 protects QUTENZA and is included in one NDA.

This patent has thirty-five patent family members in twenty-three countries.

Summary for Patent: 9,226,903

Title:	Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer or the system and use of said back layer
Abstract:	The invention relates to a transdermal therapeutic system which comprises a backing layer, an adhesive layer, a polymer layer and a removable protective layer. The adhesive layer is an organosiloxane layer and is anchored in the backing layer by siliconization.
Inventor(s):	Mueller; Walter (Andernach, DE), Leonhard; Johannes (Bendorf, DE)
Assignee:	LTS Lohmann Therapie-Systeme AG (Andernach, DE)
Application Number:	11/661,530
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 9,226,903

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 9,226,903

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	10 2004 044 578	Sep 13, 2004

PCT Information
PCT Filed	September 06, 2005	PCT Application Number:	PCT/EP2005/009547
PCT Publication Date:	March 23, 2006	PCT Publication Number:	WO2006/029740

International Family Members for US Patent 9,226,903

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	050621
Australia	2005284436
Brazil	PI0515270
Canada	2578534